Results

Total Results: 1,544 records

Showing results for "drug".

341. Topic Brief: Updating Pharmacotherapy for Adults with Alcohol Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/topic-brief-updating-pharmacotherapy.pdf
     September 30, 2022 - According to the Substance Abuse and Mental Health Services Administration’s National Survey on Drug … , Naltrexone, and Acamprosate) are approved for the treatment of AUD by the United States Food and Drug … Clin Drug Investig. 2018 Feb;38(2):147-55. doi: https://doi.org/10.1007/s40261-017-0590-4. … Clin Drug Investig. 2016 Nov;36(11):935-44. doi: https://doi.org/10.1007/s40261-016-0439-2. … Drug Alcohol Depend. 2020 Sep 1;214:108149. doi: https://doi.org/10.1016/j.drugalcdep.2020.108149.

342. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
     January 01, 2015 - Food and Drug Administration (FDA) for treatment of type 2 diabetes. … benefit and risk attributable to these drugs or may alter the strength of evidence on some of the drug … Center for Drug Evaluation and Research. Guidance for Industry. … Food and Drug Administration. … FDA Drug Safety Communication: FDA requires removal of some prescribing and dispensing restrictions

343. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - (i.e., continuation phase) or recurrence (i.e., maintenance phase) when a patient: • continues the drug … indications (major depressive disorder, dysthymia, minor depression, subsyndromal depressive disorder), drug … We assessed statistically each of the 78 possible drug comparisons of second-generation antidepressants … full-text articles excluded: 7 Foreign languages 10 Too short of duration 84 Wrong population 142 Wrong drug … meta-analyses on the response to treatment (at least 50 percent improvement from baseline) for six drug–drug

344. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
     January 31, 2013 - Additional devices designed to reduce restenosis (cryoplasty balloons, cutting balloons, drug-eluting … balloons, and drug-eluting stents) are currently being evaluated in RCTs. … What are the significant safety concerns associated with each treatment strategy (e.g., adverse drug … What are the significant safety concerns associated with each treatment strategy (e.g., adverse drug … What are the significant safety concerns associated with each treatment strategy (e.g., adverse drug

345. Abnormal-Uterine-Bleeding Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
     March 01, 2013 - We obtained package inserts for each KQ1 included drug intervention. … Administration sources discussed in the main document and do not have risks of drug- drug interactions … Pharmacoepidemiol Drug Saf 2003 Jul-Aug;12(5):371-7. PMID: 12899110. 95. … Drug Saf 2011 Jan 1;34(1):83-8. PMID: 21142273. 97. … New Drug Application: 22-430 (Tranexamic Acid) Summary Review.Center for Drug Evaluation and Research

346. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
     March 08, 2012 - Food and Drug Administration (FDA) for the treatment of SAR. … Drug class review: nasal corticosteroids: final report update 1. … Drug class review: newer antihistamines: final report update 2. … Food and Drug AdministrationCenter for Drug Evaluation and Research. … Food and Drug Administration; April 2000.

347. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
     November 02, 2018 - Food and Drug Administration (FDA) since before the 2008 AAFP/ACP guideline, numerous new trials of … In general, the figure illustrates how prescription or nonprescription drug treatment versus control … Finally, it illustrates how the effect of drug treatments versus control on BPSD, patient quality of … Eliminated sleep medications for list of prescription drug categories. … Table 2 Antidepressants, other was listed as an included drug class for treatment of BPSD.

348. S116 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
     October 01, 2007 - The PACE drug benefit pays for all outpatient drug treatment with a small copayment from $6 to $10. … APM initiators to guard against selection bias among prevalent users from early symptom emergence, drug … Frequency of Concomitant Prescribing of Tricyclic Antidepressants and Antipsychotic Medications Drug … Therefore, the method is most appropriately used to assess very short-term drug effects in which such … Pharmacoepidemiol Drug Saf. 2006;15:291–303. 19. Sturmer T, Schneeweiss S, Avorn J, et al.

349. women-hiv-protocol-160301 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
     March 01, 2016 - lives because of effective ART treatment.15 The effect of hormonal replacement therapy, as well as drug … /drug interactions with antiretroviral treatments, is also not well elucidated. … The problem of drug/drug interactions and possible increased side effects between antiretrovirals and … HIV infection, drug use, and onset of natural menopause. … Management of HIV/AIDS in older patients- drug/drug interactions and adherence to antiretroviral therapy

350. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
     March 01, 2010 - ACEIs in patients with heart failure (HF) and left ventricular systolic dysfunction established this drug … outcome than those not receiving the drug. … group must survive until drug therapy is initiated, while patients in the control group are at risk … Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology … Pharmacoepidemiol Drug Saf 1998;7(4):275-280. 24. Suissa S.

351. Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
     August 08, 2019 - Usual care, another opioid, nonopioid drug, or noninvasive, nonpharmacological therapy e. … National Institutes of Health National Institute on Drug Abuse. Overdose Death Rates. 2019. … Drug Alcohol Depend. 2019 Jan 1;194:166-72. doi: 10.1016/j.drugalcdep.2018.09.022. … Drug Monitoring/ 17 31. (urine adj7 (screen$ or test$ or detect$)).ti,ab,kf. 32. … Drug Overdose/ 35. or/27-34 36. risk$.ti,ab,kf. 37.

352. Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
     April 21, 2015 - In the early 1990s, the Federal Drug Administration (FDA) approval of medications for BPH shifted LUTS … prostates with either agent are supported by systematic reviews.10, 13 Recently, newer drugs and other drug … Common medications used to treat LUTS associated with BPH Drug class - Mechanism of action Medication … , drug manufacturer, device trade name, keyword] 109. exp Product Surveillance, Postmarketing/ 110 … . exp "Drug-Related Side Effects and Adverse Reactions"/ 111. exp Adverse Drug Reaction Reporting Systems

353. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - Food and Drug Administration (FDA) approved protease inhibitors (boceprevir and telaprevir) as a treatment … existing antiviral drugs, and the duration of treatment may change with the introduction of the new drug … programs, medication use training), increasing the convenience of medication use (e.g., simplifying drug … Food and Drug Administration; HCV = hepatitis C virus; KQ = key question; RCT = randomized controlled … We will record authors’ definitions of SVR, drug resistance, histological response, and quality of

354. Making Healthcare Safer IV: Supply Chain Disruption Monitoring Programs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-protocol.pdf
     January 01, 2024 - Food and Drug Administration about permanent discontinuances or manufacturing interruptions that are … Supply Chain Resilience and Shortage Coordinator role, along with a number of policies to prevent drug … These can include drug/device shortages, delays in care which can result in sourcing inferior or … , which led to supply shortages that affected healthcare workers’ ability to deliver care safely, drug … Policy considerations to prevent drug shortages and mitigate supply chain vulnerabilities in the United

355. Updating Current Effectiveness Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
     September 15, 2008 - As part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Congress directed … Initial work in this program originates from Section 1013 of the Medicare Prescription Drug, Improvement … Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults … would produce prima facie evidence that a conclusion was out of date, such as the withdrawal of a drug … from the market, a black box warning) or the availability of a new drug within class (the latter being

356. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
     January 10, 2012 - Food and Drug Administration (FDA) for psoriasis treatment. … FDA-approved biologic systemic and targeted therapies for plaque psoriasis Drug Name* Brand Name ( … FDA-approved nonbiologic systemic therapy for plaque psoriasis Drug Name* Brand Name (dosage form … Food and Drug Administration Source: www.effectivehealthcare.ahrq.gov Published Online: … Food and Drug Administration (FDA) will be included in this review (Tables 1–5).

357. Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-jaw-rapid-response.pdf
     May 01, 2025 - likelihood of MRONJ in comparison to patients on IV administration of another type of bisphosphonate drug … uses for antiangiogenic drugs are being explored across osteoporosis, such as current use with BP drug … canal ● Interventions other than professional dental services ● Home oral hygiene practices ● Drug … For patients at high risk for MRONJ, a drug holiday may be considered until the bone is completely … - associated OR drug-induced OR drug-related OR medication-associated OR medication-induced OR medication-related

358. Topic 0590 Strategies to Treat and Manage Infantile Hemangioma NSD FINAL_SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0715-140408.pdf
     May 29, 2025 - Topic 0590 Strategies to Treat and Manage Infantile Hemangioma NSD FINAL_SJ Strategies to Treat and Manage Infantile Hemangioma Nomination Summary Document …

359. Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
     November 27, 2012 - “Studies of injection drug users report prevalences ranging from 33 to 81 percent.” … older studies of older injection drug users." … One study of young injection drug users in the U.S. … Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. … Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

360. Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
     February 01, 2012 - Food and Drug Administration, Division of Psychiatry Products Silver Spring, MD Laurence Greenhill … Food and Drug Administration-approved second-generation antipsychotics Generic Name Indications Age … Finding a drug-placebo difference equivalent to the minimum difference between drug and no treatment … Even if a between-drug difference were equivalent to the maximum between-drug difference in the study … Pharmacoepidemiol Drug Saf 2010 May;19(5):429-35. PMID: 20306454. 5.